Phase 3 Study Update of PA32540 for Prevention of Cardiovascular Disease - MPR
Links shared publicly online about this topic.
- 0total visits
View full resource at empr.com
Most Recently Shared on March 22, 2012 at 3:45 pm By:
medicalnewstoday.com — “Pervasis Therapeutics announced that the first cohort of patients has been fully enrolled in the Phase 1/2 clinical study of PVS-10200, an investigational new drug under development to prevent res” View full resource at medicalnewstoday.com
Most Recently Shared on June 23, 2010 at 12:37 pm By: